Review
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Crit Care Med. Jul 9, 2021; 10(4): 81-101
Published online Jul 9, 2021. doi: 10.5492/wjccm.v10.i4.81
What we learned in the past year in managing our COVID-19 patients in intensive care units?
Jain Nitesh, Rahul Kashyap, Salim R Surani
Jain Nitesh, Department of Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States
Rahul Kashyap, Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, United States
Salim R Surani, Department of Medicine, Texas A&M University, Corpus Christi, TX 78404, United States
Author contributions: Surani SR and Kashyap R have contributed to the idea, review of data and manuscript; Nitesh J has also been involved in data search and initial write-up.
Conflict-of-interest statement: There are nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Salim R Surani, FCCP, MD, Professor, Department of Medicine, Texas A&M University, 701 Ayers, Corpus Christi, TX 78404, United States. srsurani@gmail.com
Received: February 16, 2021
Peer-review started: February 16, 2021
First decision: March 31, 2021
Revised: April 7, 2021
Accepted: May 17, 2021
Article in press: May 17, 2021
Published online: July 9, 2021
Processing time: 140 Days and 23 Hours
Core Tip

Core Tip: Severe acute respiratory syndrome coronavirus 2 transmission and the inpatient therapeutic management of coronavirus disease 2019 has been subject of immense research in the past one year. Our knowledge and understanding of the virus and the treatment of the disease continue to evolve. We attempt to summarize the progress made in a concise but comprehensive manner along with our insights into future directions.